BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
rs2230926
,
ZBTB7A
,
Metabolism of xenobiotics
,
HIV infection
,
Stem cell
,
Phenobarbital
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
TNBC
Summary
General Info
Curated Studies
Most Correlated Studies
Breast tumor samples from three different subtypes- TNBC, non-TNBC and HER2-positive
Breast tumors of TNBC patients before neoadjuvant chemotherapy with cisplatin and bevacizumab
Triple negative breast cancer cells with STAT3 siRNA knockdown
Triple negative breast cancer FFPE sections from African American and Caucasian patients
Triple-negative breast cancers with residual disease that have recurred after chemotherapy
Explore Curated Studies Results
Literature
Most Relevant Literature
The Achilles heel of TNBCs: Ferroptosis heterogeneity.
Knockdown of ABHD11‑AS1 prevents the procession of TNBC by upregulating miR‑199a‑5p.
The Potential of PSMA as a Vascular Target in TNBC.
Cancer stem cells in TNBC.
Two effective models based on comprehensive lipidomics and metabolomics can distinguish BC versus HC…
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
Epidemiology of TNBC in Asyut Clinical Oncology Department
FUSCC Refractory TNBC Umbrella (FUTURE)
Onvansertib + Paclitaxel In TNBC
Sacituzumab Govitecan In TNBC
Implantable Microdevice for TNBC - Pilot Study
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ